P

Assignee

BAXTER AG

AT70 patents

Top patents by PatentIndex Score

US6936441B2Aug 30, 2005

Recombinant cell clones having increased stability and methods of making and using the same

BAXTER AG160 citations99
US6475725B1Nov 5, 2002

Recombinant cell clones having increased stability and methods of making and using the same

BAXTER AG119 citations99
US6224862B1May 1, 2001

Pharmaceutical preparation for treating blood coagulation disorders

BAXTER AG88 citations99
US6620125B1Sep 16, 2003

Method and device for mixing and applying components of differing viscosities

BAXTER AG104 citations98
US6372223B1Apr 16, 2002

Influenza virus vaccine composition

BAXTER AG101 citations98
US7094574B2Aug 22, 2006

Recombinant cell clones having increased stability and methods of making and using the same

BAXTER AG32 citations96
US7033590B1Apr 25, 2006

Factor IX/factor IXa activating antibodies and antibody derivatives

BAXTER AG47 citations96
US6228613B1May 8, 2001

Stable factor VIII/von Willebrand factor complex

BAXTER AG53 citations96
US6146873ANov 14, 2000

Production of orthomyxoviruses in monkey kidney cells using protein-free media

BAXTER AG158 citations96
US6017891AJan 25, 2000

Stable preparation for the treatment of blood coagulation disorders

BAXTER AG78 citations96
US6013620AJan 11, 2000

Pharmaceutical composition for the treatment of blood coagulation diseases, methods for the production thereof and its use

BAXTER AG79 citations96
US6316226B1Nov 13, 2001

Proteins with Factor VIII activity: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them

BAXTER AG143 citations95
US6114146ASep 5, 2000

Expression plasmid, a fusion protein, a transfected eukaryotic cell line, a method of producing foreign proteins, a foreign protein preparation as well as a pharmaceutical composition

BAXTER AG94 citations95
US6926894B2Aug 9, 2005

Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV

BAXTER AG39 citations94
US6649162B1Nov 18, 2003

Hemostatic sponge based on collagen

BAXTER AG86 citations93
US6358534B1Mar 19, 2002

Immunotolerant prothrombin complex preparation

BAXTER AG32 citations93
US7220569B2May 22, 2007

Nucleic acids encoding factor X analogues having a modified protease cleavage site

BAXTER AG37 citations92
US6958322B1Oct 25, 2005

Factor X analog with an improved ability to be activated

BAXTER AG18 citations92
US6905846B2Jun 14, 2005

Nucleic acids encoding factor X deletion mutants and analogues thereof

BAXTER AG15 citations92
US6777390B1Aug 17, 2004

Stable blood coagulation inhibitor-free factor vii preparation and method for preparing same

BAXTER AG29 citations92
US6579723B1Jun 17, 2003

Method of recovering highly purified vWF or factor VIII/vWF-complex

BAXTER AG34 citations92
US6573071B1Jun 3, 2003

Factor X analogues with a modified protease cleavage site

BAXTER AG29 citations92
US6562598B1May 13, 2003

Factor X deletion mutants and analogues thereof

BAXTER AG27 citations92
US6465624B1Oct 15, 2002

Purification of von-Willebrand factor by cation exchanger chromatography

BAXTER AG31 citations92
US6265183B1Jul 24, 2001

Direct molecular cloning of foreign genes into poxviruses and methods for the preparation of recombinant proteins

BAXTER AG23 citations92
US6221363B1Apr 24, 2001

Vaccine for the prevention of lyme disease

BAXTER AG15 citations92
US6210929B1Apr 3, 2001

Fusion protein comprising a furin derivative or a derivative of a furin analogue and a heterologous sequence

BAXTER AG43 citations92
US6165711ADec 26, 2000

Process for disintegrating nucleic acids and preparing biological products of guaranteed quality

BAXTER AG19 citations92
US6136321AOct 24, 2000

Method of inactivating lipid-enveloped viruses

BAXTER AG50 citations92
US6103693AAug 15, 2000

Method for isolation of highly pure von willebrand factor

BAXTER AG27 citations92
US6103244AAug 15, 2000

Methods for generating immune responses employing modified vaccinia of fowlpox viruses

BAXTER AG36 citations92
US6086871AJul 11, 2000

Prothrombin derivatives

BAXTER AG39 citations92
US7005502B1Feb 28, 2006

Pharmaceutical preparation comprising vWF propeptide

BAXTER AG24 citations91
US6596526B1Jul 22, 2003

Furin polypeptides with improved characteristics

BAXTER AG20 citations91
US6548729B1Apr 15, 2003

Fibrin sponge

BAXTER AG63 citations91
US6270672B1Aug 7, 2001

Devices and methods for removing pathogens from biological fluids

BAXTER AG39 citations90
US7241603B2Jul 10, 2007

Method for producing a preparation based on fibrinogen and fibronectin as well as protein compositions obtainable according to this method

BAXTER AG25 citations89
US6579537B2Jun 17, 2003

Method for producing fibronectin and fibrinogen compositions using a polyalkylene glycol and glycine or β-alanine

BAXTER AG27 citations89
US6506365B1Jan 14, 2003

Fibrin/fibrinogen binding conjugate

BAXTER AG14 citations89
US6974792B2Dec 13, 2005

Alpha 1-antitrypsin preparation as well as a method for producing the same

BAXTER AG24 citations85
US7892802B2Feb 22, 2011

Fibrinogen-based tissue adhesive containing an elastase inhibitor

BAXTER AG7 citations83
US6307032B1Oct 23, 2001

Highly purified factor VIII complex

BAXTER AG15 citations83
US6953837B2Oct 11, 2005

Factor VIII/vWF complexes and compositions

BAXTER AG12 citations82
US6165974ADec 26, 2000

Pharmaceutical preparation for treating blood coagulation disorders

BAXTER AG10 citations82
US6099837AAug 8, 2000

Pharmaceutical preparation for treating blood coagulation disorders

BAXTER AG12 citations82
US6039945AMar 21, 2000

Pharmaceutical preparation for treating blood coagulation disorders

BAXTER AG13 citations82
US7279161B2Oct 9, 2007

Factor IX/factor IXa activating antibodies and antibody derivatives

BAXTER AG6 citations74
US6414125B1Jul 2, 2002

Method of chromatographically purifying or fractionating, respectively, von Willebrand factor from a VWF-containing starting material

BAXTER AG9 citations74
US6010844AJan 4, 2000

Methods of preparing and recovering proteins

BAXTER AG13 citations74
US7091015B1Aug 15, 2006

Fibrinogen-based tissue adhesive

BAXTER AG7 citations73

Showing the top 50 of 70 patents by PatentIndex Score.